BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 33460583)

  • 1. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
    Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.
    van Riel M; Brison N; Baetens M; Blaumeiser B; Boemer F; Bourlard L; Bulk S; De Leener A; Désir J; Devriendt K; Dheedene A; Duquenne A; Fieremans N; Fieuw A; Gatot JS; Grisart B; Janssens S; Khudashvili N; Lannoo L; Marichal A; Meunier C; Palmeira L; Parijs I; Pichon B; Roets E; Sammels E; Smits G; Suenaert M; Sznajer Y; Van den Bogaert K; Vancoillie L; Vandeputte L; Vantroys E; Vermeesch JR; Janssens K
    Obstet Gynecol; 2021 Jun; 137(6):1102-1108. PubMed ID: 33957658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis.
    Judah H; Gil MM; Syngelaki A; Galeva S; Jani J; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):178-189. PubMed ID: 33838069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of crown-rump length discordance at 11 to 14 weeks in dichorionic twins.
    Janssen MK; Levine LD; Bromley B; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramanian A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao R; Crowder A; Shree R; McLennan G; Dugoff L;
    Am J Obstet Gynecol; 2024 Jan; 230(1):83.e1-83.e11. PubMed ID: 37487855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
    Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
    Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis.
    He Y; Wang Y; Li Z; Chen H; Deng J; Huang H; He X; Zeng W; Liu M; Huang B; Chen P
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):731-743. PubMed ID: 32166736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.